Coming soon from SECUADO

Watch Gregory W. Mattingly, MD discuss clinical information about SECUADO®

Learn about how SECUADO can benefit different patients in your practice

Your patients and their caregivers may find these resources helpful.

These independent third-party organizations are not affiliated with Noven. Each third-party organization has its own eligibility criteria and evaluation process, and Noven cannot guarantee that patients will receive assistance.

    You are now leaving the SECUADO® (asenapine) transdermal system website and moving to an external website independently operated and not managed by Noven

    The site you are about to enter is intended specifically for US healthcare professionals.

    Click continue if you are a US healthcare professional.